Protein WP_013645061.1 in Methanobacterium lacus AL-21
Annotation: NCBI__GCF_000191585.1:WP_013645061.1
Length: 323 amino acids
Source: GCF_000191585.1 in NCBI
Candidate for 18 steps in catabolism of small carbon sources
Pathway | Step | Score | Similar to | Id. | Cov. | Bits | Other hit | Other id. | Other bits |
D-cellobiose catabolism | msiK | lo | MsiK protein, component of The cellobiose/cellotriose (and possibly higher cellooligosaccharides), CebEFGMsiK [MsiK functions to energize several ABC transporters including those for maltose/maltotriose and trehalose] (characterized) | 33% | 55% | 137.1 | Linearmycin resistance ATP-binding protein LnrL; EC 7.6.2.- | 38% | 215.3 |
L-isoleucine catabolism | livG | lo | ABC transporter ATP-binding protein-branched chain amino acid transport, component of The branched chain hydrophobic amino acid transporter, LivJFGHM (characterized) | 33% | 93% | 136.3 | Linearmycin resistance ATP-binding protein LnrL; EC 7.6.2.- | 38% | 215.3 |
L-leucine catabolism | livG | lo | ABC transporter ATP-binding protein-branched chain amino acid transport, component of The branched chain hydrophobic amino acid transporter, LivJFGHM (characterized) | 33% | 93% | 136.3 | Linearmycin resistance ATP-binding protein LnrL; EC 7.6.2.- | 38% | 215.3 |
D-maltose catabolism | malK | lo | ABC-type maltose transporter (subunit 3/3) (EC 7.5.2.1) (characterized) | 32% | 68% | 136.3 | Linearmycin resistance ATP-binding protein LnrL; EC 7.6.2.- | 38% | 215.3 |
L-valine catabolism | livG | lo | ABC transporter ATP-binding protein-branched chain amino acid transport, component of The branched chain hydrophobic amino acid transporter, LivJFGHM (characterized) | 33% | 93% | 136.3 | Linearmycin resistance ATP-binding protein LnrL; EC 7.6.2.- | 38% | 215.3 |
L-arabinose catabolism | xacJ | lo | Xylose/arabinose import ATP-binding protein XacJ; EC 7.5.2.13 (characterized, see rationale) | 33% | 56% | 133.7 | Linearmycin resistance ATP-binding protein LnrL; EC 7.6.2.- | 38% | 215.3 |
2'-deoxyinosine catabolism | nupA | lo | RnsB, component of The (deoxy)ribonucleoside permease; probably takes up all deoxy- and ribonucleosides (cytidine, uridine, adenosine and toxic analogues, fluorocytidine and fluorouridine tested), but not ribose or nucleobases (characterized) | 31% | 63% | 130.2 | Linearmycin resistance ATP-binding protein LnrL; EC 7.6.2.- | 38% | 215.3 |
L-phenylalanine catabolism | livG | lo | ABC transporter ATP-binding protein (characterized, see rationale) | 31% | 93% | 127.9 | Linearmycin resistance ATP-binding protein LnrL; EC 7.6.2.- | 38% | 215.3 |
L-proline catabolism | HSERO_RS00895 | lo | ABC transporter ATP-binding protein (characterized, see rationale) | 31% | 93% | 127.9 | Linearmycin resistance ATP-binding protein LnrL; EC 7.6.2.- | 38% | 215.3 |
L-serine catabolism | Ac3H11_1693 | lo | ABC transporter ATP-binding protein (characterized, see rationale) | 31% | 93% | 127.9 | Linearmycin resistance ATP-binding protein LnrL; EC 7.6.2.- | 38% | 215.3 |
L-tyrosine catabolism | Ac3H11_1693 | lo | ABC transporter ATP-binding protein (characterized, see rationale) | 31% | 93% | 127.9 | Linearmycin resistance ATP-binding protein LnrL; EC 7.6.2.- | 38% | 215.3 |
L-alanine catabolism | braG | lo | High-affinity branched-chain amino acid transport ATP-binding protein BraG, component of Branched chain amino acid uptake transporter. Transports alanine (characterized) | 35% | 92% | 124.4 | Linearmycin resistance ATP-binding protein LnrL; EC 7.6.2.- | 38% | 215.3 |
L-isoleucine catabolism | livF | lo | High-affinity branched-chain amino acid transport ATP-binding protein BraG, component of Branched chain amino acid uptake transporter. Transports alanine (characterized) | 35% | 92% | 124.4 | Linearmycin resistance ATP-binding protein LnrL; EC 7.6.2.- | 38% | 215.3 |
L-leucine catabolism | livF | lo | High-affinity branched-chain amino acid transport ATP-binding protein BraG, component of Branched chain amino acid uptake transporter. Transports alanine (characterized) | 35% | 92% | 124.4 | Linearmycin resistance ATP-binding protein LnrL; EC 7.6.2.- | 38% | 215.3 |
L-serine catabolism | braG | lo | High-affinity branched-chain amino acid transport ATP-binding protein BraG, component of Branched chain amino acid uptake transporter. Transports alanine (characterized) | 35% | 92% | 124.4 | Linearmycin resistance ATP-binding protein LnrL; EC 7.6.2.- | 38% | 215.3 |
L-threonine catabolism | braG | lo | High-affinity branched-chain amino acid transport ATP-binding protein BraG, component of Branched chain amino acid uptake transporter. Transports alanine (characterized) | 35% | 92% | 124.4 | Linearmycin resistance ATP-binding protein LnrL; EC 7.6.2.- | 38% | 215.3 |
L-valine catabolism | livF | lo | High-affinity branched-chain amino acid transport ATP-binding protein BraG, component of Branched chain amino acid uptake transporter. Transports alanine (characterized) | 35% | 92% | 124.4 | Linearmycin resistance ATP-binding protein LnrL; EC 7.6.2.- | 38% | 215.3 |
L-phenylalanine catabolism | livF | lo | High-affinity branched-chain amino acid transport ATP-binding protein (characterized, see rationale) | 33% | 97% | 117.9 | Linearmycin resistance ATP-binding protein LnrL; EC 7.6.2.- | 38% | 215.3 |
Sequence Analysis Tools
View WP_013645061.1 at NCBI
Find papers: PaperBLAST
Find functional residues: SitesBLAST
Search for conserved domains
Find the best match in UniProt
Compare to protein structures
Predict transmenbrane helices: Phobius
Predict protein localization: PSORTb
Find homologs in fast.genomics
Fitness BLAST: loading...
Sequence
MTKYALELNNLSKKYGDFTAVDDLSLQVKEGEIFGFLGPNGAGKSTTIRMLCTLALPTSG
SAKIAGYDLSKDSGKVRENIGLVAEKLIMYDGLTAGQNLRFFGKLYGIPKKKLEKRIDEL
LELIDMKKWKDTKINTFSTGMKQRINIIRALLAEPKIIFMDEPTLGLDPQTTFSVREIIR
DINSKGVTVILTTHAMVEAEALSDRVAIIDHGKIAALDTPENLKKMLSDTDITIFKMEIT
NLTVEMIENIKSLDVVTALSKQDEHNIKISAKGPDSLEEIIDTIRFDGGKISSIANINDA
TLEDVFLTVTGKEIRDTPAANSS
This GapMind analysis is from Apr 09 2024. The underlying query database was built on Sep 17 2021.
Links
Downloads
Related tools
About GapMind
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using
ublast (a fast alternative to protein BLAST)
against a database of manually-curated proteins (most of which are experimentally characterized) or by using
HMMer with enzyme models (usually from
TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
- ublast finds a hit to a characterized protein at above 40% identity and 80% coverage, and bits >= other bits+10.
- (Hits to curated proteins without experimental data as to their function are never considered high confidence.)
- HMMer finds a hit with 80% coverage of the model, and either other identity < 40 or other coverage < 0.75.
where "other" refers to the best ublast hit to a sequence that is not annotated as performing this step (and is not "ignored").
Otherwise, a candidate is "medium confidence" if either:
- ublast finds a hit at above 40% identity and 70% coverage (ignoring otherBits).
- ublast finds a hit at above 30% identity and 80% coverage, and bits >= other bits.
- HMMer finds a hit (regardless of coverage or other bits).
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps."
For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways.
For diverse bacteria and archaea that can utilize a carbon source, there is a complete
high-confidence catabolic pathway (including a transporter) just 38% of the time, and
there is a complete medium-confidence pathway 63% of the time.
Gaps may be due to:
- our ignorance of proteins' functions,
- omissions in the gene models,
- frame-shift errors in the genome sequence, or
- the organism lacks the pathway.
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory